1,655
Views
1
CrossRef citations to date
0
Altmetric
Review Article

Psychometric Properties of Scales for Assessing the Vision-related Quality of Life of People with Low Vision: A Systematic Review

, , , , , , & show all
Pages 239-248 | Received 28 Sep 2021, Accepted 21 Jun 2022, Published online: 05 Jul 2022

References

  • de Boer Mr, Moll AC, de Vet Hcw, et al. Psychometric properties of vision-related quality of life questionnaires: a systematic review. Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists). 2004;24:257–273. doi:10.1111/j.1475-1313.2004.00187.x.
  • Bourne RRA, Flaxman SR, Braithwaite T, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(9):e888–e897. doi:10.1016/S2214-109X(17)30293-0.
  • World Health Organization. Summary world report on disability World Health Organization & World Bank . . 2011; 1–24
  • Bourne RRA, Steinmetz JD, Flaxman S, et al. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9:e130–e143. doi:10.1016/S2214-109X(20)30425-3.
  • Stelmack J. Quality of life of low-vision patients and outcomes of low-vision rehabilitation. Optom Vis Sci. 2001;78:335–342. doi:10.1097/00006324-200105000-00017.
  • Burton MJ, Ramke J, Marques AP, et al. The Lancet global health commission on global eye health: vision beyond 2020. Lancet Global Health. 2021;9:e489–e551. doi:10.1016/S2214-109X(20)30488-5.
  • Pérez Mañá L, López Genís Cardona Torradeflot A A. Low VIsion Quality of Life (LVQOL).
  • Suárez BR, Silva YH, Rodríguez RL. Escala NEI VFQ-25 como instrumento de medición de la calidad de vida relativa a la visión. Rev Cuba Oftalmol. 2017;30
  • Palencia Flórez DC, Camacho López PA, Cáceres Manrique F de M. Confiabilidad de la escala NEI VFQ-25 en una población colombiana con enfermedad ocular crónica. Rev Mex Oftalmol. 2016;90:174–181.
  • Wolffsohn JS, Cochrane AL. Design of the low vision quality-of-life questionnaire (LVQOL) and measuring the outcome of low-vision rehabilitation. Am J Ophthalmol. 2000;130:793–802. doi:10.1016/S0002-9394(00)00610-3.
  • Pérez-Mañá L, Cardona G, Pardo Cladellas Y, et al. Translation and cultural adaptation into Spanish of the low vision quality of life questionnaire. Arch Soc Esp Oftalmol. 2019;94:384–390. doi:10.1016/j.oftal.2019.02.004.
  • Stelmack JA, Tang XC, Wei Y, et al. Outcomes of the veterans affairs lowvision intervention trial II (lovit II) a randomized clinical trial. JAMA Ophthalmol. 2017;135:96–104. doi:10.1001/jamaophthalmol.2016.4742.
  • Weih LM, Hassell JB, Keeffe J. Assessment of the Impact of Vision Impairment. IOVS. 2002;43:927–935.
  • Lamoureux EL, Pallant JF, Pesudovs K, et al. The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and rasch analysis. Invest Ophthalmol Vis Sci. 2007;48:1001–1006. doi:10.1167/iovs.06-0361.
  • Mjtpbpj R, Tongsomboon, J, Bhurayanontachai, P, and Jirarattanasopa, P. The Impact of Vision Impairment (IVI) Questionnaire; Validation of the Thai-Version and the Implementation on Vision-Related Quality of Life in Thai Rural Community PLoS One. 2016;11(5) :e0155509 doi:10.1371/journal.pone.0155509.
  • Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item national eye institute visual function questionnaire. Arch Ophthalmol. 2001;119:1050–1058. doi:10.1001/archopht.119.7.1050.
  • Broman AT, Munoz B, West SK, et al. Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: proyecto VER. Invest Ophthalmol Vis Sci. 2001;42:606–613.
  • Rossi GCM, Milano G, Tinelli C. The Italian version of the 25-item national eye institute visual function questionnaire: translation, validity, and reliability. Journal of Glaucoma. J Glaucoma. 2003;213–220. doi:10.1097/00061198-200306000-00006.
  • Suzukamo Y, Oshika T, Yuzawa M, et al. Psychometric properties of the 25-item national eye institute visual function questionnaire (NEI VFQ-25), Japanese version. Health Qual Life Outcomes. 3 Epub ahead of print 26 October 2005
  • Toprak AB, Eser E, Guler C, et al. Cross-validation of the Turkish version of the 25-item national eye institute visual functioning questionnaire (NEI-VFQ 25). Ophthalmic Epidemiol. 2005;12:259–269. doi:10.1080/09286580590967763.
  • Baker RS, Bazargan M, Calderón JL, et al. Psychometric performance of the national eye institute visual function questionnaire in latinos and non-latinos. Ophthalmology. 2006;113:1363–1371.e2. doi:10.1016/j.ophtha.2006.01.073.
  • Wang CW, Chan CLW, Jin HY. Psychometric properties of the Chinese version of the 25-item national eye institute visual function questionnaire. Optom Vis Sci. 2008;85:1091–1099. doi:10.1097/OPX.0b013e31818b9f23.
  • Labiris G, Katsanos A, Fanariotis M, et al. Psychometric properties of the Greek version of the NEI-VFQ 25. BMC Ophthalmology. 2008;8(1):1–11. doi:10.1186/1471-2415-8-4.
  • Fevzi A, Aysegul Y. Psychometric performance of the national eye institute 25-item visual function questionnaire. Patient Patient-Centered Outcomes Res. 2008;1(2):115–125. doi:10.2165/01312067-200801020-00007.
  • Mesquita Simão L, Lana-Peixoto M A, and Reis Araújo C, et al. The Brazilian version of the 25-item national eye institute visual function questionnaire: translation, reliability and validity. Arq Bras Oftalmol . 2008.
  • Chan CWS, Wong D, Lam CLK, et al. Development of a Chinese version of the national eye institute visual function questionnaire (CHI-VFQ-25) as a tool to study patients with eye diseases in Hong Kong. Br J Ophthalmol. 2009;93:1431–1436. doi:10.1136/bjo.2009.158428.
  • Suñer IJ, Kokame GT, Yu E, et al. Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials. Invest Ophthalmol Vis Sci. 2009;50:3629–3635. doi:10.1167/iovs.08-3225.
  • Lin JC, Chie WC. Psychometric validation of the Taiwan Chinese version of the 25-item national eye institute visual functioning questionnaire. J Eval Clin Pract. 2010;16:619–626. doi:10.1111/j.1365-2753.2010.01535.x.
  • Dougherty BE, Bullimore MA. Comparison of scoring approaches for the NEI VFQ-25 in low vision. Optom Vis Sci. 2010;87:543–548. doi:10.1097/OPX.0b013e3181e61bd8.
  • Revicki DA, Rentz AM, Harnam N, et al. Reliability and validity of the national eye institute visual function questionnaire-25 in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010;51:712–717. doi:10.1167/iovs.09-3766.
  • Pesudovs K, Gothwal VK, Wright T, et al. Remediating serious flaws in the national eye institute visual function questionnaire. J Cataract Refract Surg. 2010;36:718–732. doi:10.1016/j.jcrs.2009.11.019.
  • Marella M, Pesudovs K, Keeffe JE, et al. The psychometric validity of the NEI VFQ-25 for use in a low-vision population. Invest Ophthalmol Vis Sci. 2010;51:2878–2884. doi:10.1167/iovs.09-4494.
  • Orr P, Rentz AM, Margolis MK, et al. Validation of the national eye institute visual function questionnaire-25 (NEI VFQ-25) in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52:3354–3359. doi:10.1167/iovs.10-5645.
  • Sørensen MS, Andersen S, and Gitte Østerby Henningsen CTL, et al. Danish version of visual function questionnaire-25 and its use in age-related macular degeneration. Danish Medical Bulletin . Dan Med Bul. 2011;58:1–5
  • Piemarocchi S, Varano M, Parravano M, et al. Quality of vision index: a new method to appraise visual function changes in age-related macular degeneration. Eur J Ophthalmol. 2011;21:55–66. doi:10.5301/EJO.2010.1519.
  • Lloyd AJ, Loftus J, Turner M, et al. Psychometric validation of the visual function questionnaire-25 in patients with diabetic macular edema. Health Qual Life Outcomes. 2013;11:1–11. doi:10.1186/1477-7525-11-10.
  • Abdelfattah NS, Amgad M, Salama AA, et al. Development of an Arabic version of the national eye institute visual function questionnaire as a tool to study eye diseases patients in Egypt. Int J Ophthalmol. 2014;7:891–897. doi:10.3980/j.2222-3959.2014.05.27.
  • To KG, Meuleners L, and Chen HY, et al. Assessing the test-retest repeatability of the Vietnamese version of the national eye institute 25-item visual function questionnaire among bilateral cataract patients for a Vietnamese population. Australas J Ageing. 2014. 33 Epub ahead of print 2014
  • Kovac B, Vukosavljevic M, Djokic Kovac J, et al. Validation and cross-cultural adaptation of the national eye institute visual function questionnaire (NEI VFQ-25) in Serbian patients. Health Qual Life Outcomes. 13 Epub ahead of print 15 September 2015
  • Petrillo J, Bressler NM, Lamoureux E, et al. Development of a new Rasch-based scoring algorithm for the national eye institute visual functioning questionnaire to improve its interpretability. Health Qual Life Outcomes. 15 Epub ahead of print 14 August 2017
  • Alvarez-Peregrina C, Sánchez-Tena MA, Caballé-Fontanet D, et al. Adaptación cultural y validación al castellano del cuestionario national eye institute visual function questionnaire 25 - dialnet. Arch Soc Esp Oftalmol. 2018;93:586–591. doi:10.1016/j.oftal.2018.05.017.
  • Sivaprasad S, Tschosik E, Kapre A, et al. Reliability and construct validity of the NEI VFQ-25 in a Subset Of Patients With Geographic Atrophy From the Phase 2 Mahalo Study. Am J Ophthalmol. 2018;190:1–8. doi:10.1016/j.ajo.2018.03.006.
  • Jelin E, Wisløff T, Moe MC, et al. Psychometric properties of the national eye institute visual function questionnaire (NEI-VFQ 25) in a Norwegian population of patients with neovascular age-related macular degeneration compared to a control population. Health Qual Life Outcomes. 17 Epub ahead of print 14 August 2019
  • Abe RY, Medeiros FA, Davi MA, et al. Psychometric properties of the Portuguese version of the national eye institute visual function questionnaire-25. PLOS ONE. 2019;14:e0226086. doi:10.1371/journal.pone.0226086.
  • Nordmann JP, Vialal M, Sullivan K, et al. Psychometric validation of the National Eye Institute Visual Function Questionnaire - 25 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucoma. PharmacoEconomics. 2004;22:197–206. doi:10.2165/00019053-200422030-00005.
  • Langelaan M, Van Nispen RMA, Knol DL, et al. Visual functioning questionnaire: reevaluation of psychometric properties for a group of working-age adults. Optom Vis Sci. 2007;84:775–784. doi:10.1097/OPX.0b013e3181334b98.
  • Palencia-Flórez DC, Orozco-Vargas LC, de M C-MF, et al. Validez de constructo de la escala NEI-VFQ-25 en una población colombiana. Rev Cuba Oftalmol. 2017;30:1–13.
  • Clemons TE, Chew EY, Bressler SB, et al. National eye institute visual function questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS report no. 10. Arch Ophthalmol. 2003;121:211–217. doi:10.1001/archopht.121.2.211.
  • Iyigun E, Bayer A, and Tastan S, et al. Validity and reliability study for the NEI-VFO-39 scale in chronic ophthalmic diseases - Turkish version. Acta Ophthalmol (Copenh). 2010. 88 Epub ahead of print 2010
  • Mollazadegan K, Huang J, Khadka J, et al. Cross-cultural validation of the national eye institute visual function questionnaire. J Cataract Refract Surg. 2014;40:774–784. doi:10.1016/j.jcrs.2013.10.040.
  • Brösel D, Sabel BA, Franke GH, et al. Das 2-Skalen-Modell des National Eye Institute Visual Function Questionnaire (NEI-VFQ) zur Erfassung der sehbezogenen Lebensqualität. Klin Monatsbl Augenheilkd. 2017;234:719–725. doi:10.1055/s-0042-109700.
  • Mangione CM, Lee PP, Pitts J, et al. Psychometric properties of the national eye institute visual function questionnaire (NEI-VFQ). Arch Ophthalmol. 1998;116:1496–1504. doi:10.1001/archopht.116.11.1496.
  • Massof RW, Fletcher DC. Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision. Vision Res. 2001;41:397–413. doi:10.1016/S0042-6989(00)00249-2.
  • Ryan B, Court H, Margrain TH. Measuring low vision service outcomes: rasch analysis of the seven-item national eye institute visual function questionnaire. Optom Vis Sci. 2008;85:112–121. doi:10.1097/OPX.0b013e31816225dc.
  • Kodjebacheva G, Coleman AL, Ensrud KE, et al. Reliability and validity of abbreviated surveys derived from the national eye institute visual function Questionnaire: the Study of Osteoporotic Fractures. Am J Ophthalmol. 2010;149:330–340. doi:10.1016/j.ajo.2009.09.008.
  • Ratanasukon M, Tongsomboon J, Bhurayanontachai P, et al. The impact of vision impairment (IVI) questionnaire; validation of the Thai-version and the implementation on vision-related quality of life in Thai rural community. PLoS ONE. 11 Epub ahead of print 1 May 2016
  • Goldstein JE, Fenwick E, Finger RP, et al. Calibrating the impact of vision impairment (IVI): creation of a sample-independent visual function measure for patient-centered outcomes research. Transl Vis Sci Technol. 7 Epub ahead of print 1 November 2018
  • Fenwick EK, Ong PG, Sabanayagam C, et al. Assessment of the psychometric properties of the Chinese impact of vision impairment questionnaire in a population-based study: findings from the Singapore Chinese Eye Study. Qual Life Res. 2016;25:871–880. doi:10.1007/s11136-015-1141-1.
  • Mcguinness MB, Finger RP, Wu Z, et al. Properties of the impact of vision impairment and night vision questionnaires among people with intermediate age-related macular degeneration. TVST. 2019;8:1–11. doi:10.1167/tvst.8.5.3.
  • Di Maggio I, Virgili G, and Giacomelli G, et al. The veterans affairs low-vision visual functioning questionnaire-48 (VA LV VFQ-48): performance of the Italian version. Eur J Ophthalmol. 2019;3(5):1–5.
  • Stelmack JA, Szlyk JP, Stelmack TR, et al. Psychometric properties of the veterans affairs low-vision visual functioning questionnaire. Invest Ophthalmol Vis Sci. 2004;45:3919–3928. doi:10.1167/iovs.04-0208.
  • Wolffsohn JS, Cochrane AL, Watt NA. Implementation methods for vision related quality of life questionnaires. Br J Ophthalmol. 2000;84:1035–1040. doi:10.1136/bjo.84.9.1035.
  • Zou H, Zhang X, Xu X, et al. Development and psychometric tests of the Chinese-version low vision quality of life questionnaire. Qual Life Res. 2005;14:1633–1639. doi:10.1007/s11136-004-0026-5.
  • Van Nispen RMA, Knol DL, Langelaan M, et al. Re-evaluating a vision-related quality of life questionnaire with item response theory (IRT) and differential item functioning (DIF) analyses. BMC Med Res Methodol. 2011;11:125. doi:10.1186/1471-2288-11-125.
  • Idil A, Ozen M, Atak N, et al. Validity and reliability study of Turkish version on low vision with quality of life questionnaire. Int J Ophthalmol. 2011;4:546–551. doi:10.3980/j.2222-3959.2011.05.17.
  • De Boer MR, Terwee CB, De Vet HCW, et al. Evaluation of cross-sectional and longitudinal construct validity of two vision-related quality of life questionnaires: the LVQOL and VCM1. Qual Life Res. 2006;15:233–248. doi:10.1007/s11136-005-1524-9.
  • Şahlı E, İdil ŞA. Comparison of quality of life questionnaires in patients with low vision. Turk J Ophthalmol. 2021;51:83–88. doi:10.4274/tjo.galenos.2020.99975.
  • Raphael BA, Galetta KM, and Jacobs DA, et al. Validation and test characteristics of a 10-item Neuro-Ophthalmic supplement to the NEI-VFQ-25. Am J Ophthalmol. 2006; 142. Epub ahead of print 2006
  • Wagenbreth C, Sabel BA, Tönnies S, et al. Das neuroophthalmologische Supplement des NEI-VFQ: teststatistische Überprüfung und Validierung an einer Stichprobe prä- und postchiasmatisch geschädigter Patienten. Klin Monatsbl Augenheilkd. 2011;228:971–978. doi:10.1055/s-0029-1246062.
  • Stelmack JA, Tang XC, Reda DJ, et al. VA LOVIT II: a protocol to compare low vision rehabilitation and basic low vision. Ophthalmic Physiol Opt. 2012;32:461–471. doi:10.1111/j.1475-1313.2012.00933.x.
  • Acton JH, Molik B, Court H, et al. Effect of a home visit-based low vision rehabilitation intervention on visual function outcomes: an exploratory randomized controlled trial. Invest Ophthalmol Vis Sci. 2016;57:6662–6667. doi:10.1167/iovs.16-19901.
  • Lamoureux EL, Pallant JF, Pesudovs K, et al. The impact of vision impairment questionnaire: an evaluation of its measurement properties using Rasch analysis. Invest Ophthalmol Vis Sci. 2006;47:4732–4741. doi:10.1167/iovs.06-0220.
  • Finger RP, Tellis B, Crewe J, et al. Developing the impact of vision impairment-very low vision (IVI-VLV) questionnaire as part of the LoVADA protocol. Invest Ophthalmol Vis Sci. 2014;55:6150–6158. doi:10.1167/iovs.14-14731.
  • InternatIonal StandardS for VISIon rehabIlItatIon: report of the InternatIonal conSenSuS conference. 2017.